FDA seeks dismissal of Mylan's lawsuit regarding generic Lipitor

04/7/2011 | Wall Street Journal, The

The FDA petitioned a federal judge to dismiss a lawsuit from Mylan that seeks an injunction forcing the agency to deny a six-month exclusivity period for Ranbaxy Laboratories' generic version of Lipitor, Pfizer's cholesterol-lowering drug. The agency said Mylan's legal action is premature because the agency has not approved any generic Lipitor.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC